{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T12:36:14Z","timestamp":1773146174015,"version":"3.50.1"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,5,18]],"date-time":"2021-05-18T00:00:00Z","timestamp":1621296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,5,18]],"date-time":"2021-05-18T00:00:00Z","timestamp":1621296000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004869","name":"Westf\u00e4lische Wilhelms-Universit\u00e4t M\u00fcnster","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004869","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The mechanism of small-molecule stabilised protein-protein interactions is of growing interest in the pharmacological discovery process. A plethora of different substances including the aromatic sulphonamide E7820 have been identified to act by such a mechanism. The process of E7820 induced CAPER\u03b1 degradation and the resultant transcriptional down regulation of integrin \u03b12 expression has previously been described for a variety of different cell lines and been made responsible for E7820\u2019s antiangiogenic activity. Currently the application of E7820 in the treatment of various malignancies including pancreas carcinoma and breast cancer is being investigated in pre-clinical and clinical trials. It has been shown, that integrin \u03b12 deficiency has beneficial effects on bone homeostasis in mice. To transfer E7820 treatment to bone-related pathologies, as non-healing fractures, osteoporosis and bone cancer might therefore be beneficial. However, at present no data is available on the effect of E7820 on osseous cells or skeletal malignancies.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Pre-osteoblastic (MC3T3 and Saos-2) cells and endothelial (eEnd2 cells and HUVECs) cells, each of human and murine origin respectively, were investigated. Vitality assay with different concentrations of E7820 were performed. All consecutive experiments were done at a final concentration of 50\u2009ng\/ml E7820. The expression and production of integrin \u03b12 and CAPER\u03b1 were investigated by quantitative real-time PCR and western blotting. Expression of CAPER\u03b1 splice forms was differentiated by semi-quantitiative reverse transcriptase PCR.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Here we present the first data showing that E7820 can increase integrin \u03b12 expression in the pre-osteoblast MC3T3 cell line whilst also reproducing canonical E7820 activity in HUVECs. We show that the aberrant activity of E7820 in MC3T3 cells is likely due to differential activity of CAPER\u03b1 at the integrin \u03b12 promoter, rather than due to differential CAPER\u03b1 degradation or differential expression of CAPER\u03b1 spliceforms.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>The results presented here indicate that E7820 may not be suitable to treat certain malignancies of musculoskeletal origin, due to the increase in integrin \u03b12 expression it may induce. Further investigation of the differential functioning of CAPER\u03b1 and the integrin \u03b12 promoter in cells of various origin would however be necessary to more clearly differentiate between cell lines that will positively respond to E7820 from those that will not.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12885-021-08301-w","type":"journal-article","created":{"date-parts":[[2021,5,18]],"date-time":"2021-05-18T21:02:59Z","timestamp":1621371779000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["The small-molecule protein ligand interface stabiliser E7820 induces differential cell line specific responses of integrin \u03b12 expression"],"prefix":"10.1186","volume":"21","author":[{"given":"Michael David","family":"H\u00fclskamp","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Kronenberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Stange","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,5,18]]},"reference":[{"issue":"21","key":"8301_CR1","doi-asserted-by":"publisher","first-page":"2366","DOI":"10.1182\/blood-2015-07-567958","volume":"126","author":"EC Fink","year":"2015","unstructured":"Fink EC, Ebert BL. The novel mechanism of lenalidomide activity. Blood. 2015;126(21):2366\u20139. https:\/\/doi.org\/10.1182\/blood-2015-07-567958 .","journal-title":"Blood."},{"key":"8301_CR2","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1039\/C9MD00263D","volume":"10","author":"E Valeur","year":"2019","unstructured":"Valeur E, Narjes F, Ottmann C, Plowright AT. Emerging modes-of-action in drug discovery. Med Chem Comm. 2019;10:1550\u201368.","journal-title":"Med Chem Comm"},{"key":"8301_CR3","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.sbi.2016.01.004","volume":"37","author":"ES Fischer","year":"2016","unstructured":"Fischer ES, Park E, Eck MJ, Thom\u00e4 NH. SPLINTS: small-molecule protein ligand interface stabilizers. Curr Opin Struct Biol. 2016;37:115\u201322. https:\/\/doi.org\/10.1016\/j.sbi.2016.01.004 .","journal-title":"Curr Opin Struct Biol"},{"issue":"21","key":"8301_CR4","first-page":"6116","volume":"62","author":"Y Funahashi","year":"2002","unstructured":"Funahashi Y, Sugi NH, Semba T, Yamamoto Y, Hamaoka S, Tsukahara-Tamai N, et al. Sulfonamide derivative, E7820, is a unique angiogenesis inhibitor suppressing an expression of integrin alpha2 subunit on endothelium. Cancer Res. 2002;62(21):6116\u201323.","journal-title":"Cancer Res"},{"issue":"4","key":"8301_CR5","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1158\/1078-0432.CCR-0109-03","volume":"10","author":"T Semba","year":"2004","unstructured":"Semba T, Funahashi Y, Ono N, Yamamoto Y, Sugi NH, Asada M, et al. An angiogenesis inhibitor E7820 shows broad-Spectrum tumor growth inhibition in a xenograft model: possible value of integrin \u03b12 on platelets as a biological marker. Clin Cancer Res. 2004;10(4):1430\u20138. https:\/\/doi.org\/10.1158\/1078-0432.CCR-0109-03 .","journal-title":"Clin Cancer Res"},{"issue":"15_suppl","key":"8301_CR6","doi-asserted-by":"publisher","first-page":"3537","DOI":"10.1200\/jco.2010.28.15_suppl.3537","volume":"28","author":"MB Sawyer","year":"2010","unstructured":"Sawyer MB, Iqbal S, Lenz H, Lima CSR, Rossignol DP, Krivelevich I, et al. Phase II study of E7820 in combination with cetuximab in subjects (pts) with metastatic and refractory colorectal cancer (CRC). J Clin Oncol. 2010;28(15_suppl):3537. https:\/\/doi.org\/10.1200\/jco.2010.28.15_suppl.3537 .","journal-title":"J Clin Oncol"},{"issue":"1","key":"8301_CR7","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1158\/1078-0432.CCR-10-0010","volume":"17","author":"M Mita","year":"2011","unstructured":"Mita M, Kelly KR, Mita A, Ricart AD, Romero O, Tolcher A, et al. Phase I study of E7820, an Oral inhibitor of integrin \u03b1-2 expression with antiangiogenic properties, in patients with advanced malignancies. Clin Cancer Res. 2011;17(1):193\u2013200. https:\/\/doi.org\/10.1158\/1078-0432.CCR-10-0010 .","journal-title":"Clin Cancer Res"},{"issue":"3","key":"8301_CR8","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/s10637-016-0344-9","volume":"34","author":"BM Kerklaan","year":"2016","unstructured":"Kerklaan BM, Slater S, Flynn M, Greystoke A, Witteveen PO, Megui-Roelvink M, et al. A phase I, dose escalation, pharmacodynamic, pharmacokinetic, and food-effect study of \u03b12 integrin inhibitor E7820 in patients with advanced solid tumors. Investig New Drugs. 2016;34(3):329\u201337. https:\/\/doi.org\/10.1007\/s10637-016-0344-9 .","journal-title":"Investig New Drugs"},{"issue":"4","key":"8301_CR9","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1080\/15384101.2020.1711579","volume":"19","author":"SD Chilewski","year":"2020","unstructured":"Chilewski SD, Bhosale D, Dees S, Hutchinson I, Trimble R, Pontiggia L, et al. Development of CAPER peptides for the treatment of triple negative breast cancer. Cell Cycle Taylor & Francis. 2020;19(4):432\u201347. https:\/\/doi.org\/10.1080\/15384101.2020.1711579 .","journal-title":"Cell Cycle Taylor & Francis"},{"key":"8301_CR10","first-page":"1","volume":"355","author":"TB Faust","year":"2019","unstructured":"Faust TB, Yoon H, Nowak RP, Donovan KA, Li Z, Cai Q, et al. Structural complementarity facilitates E7820-mediated degradation of RBM39 by DCAF15. Nat Chem Biol. 2019;355:1\u201313.","journal-title":"Nat Chem Biol"},{"issue":"1","key":"8301_CR11","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.pbiomolbio.2015.05.002","volume":"119","author":"D Bier","year":"2015","unstructured":"Bier D, Thiel P, Briels J, Ottmann C. Stabilization of protein\u2013protein interactions in chemical biology and drug discovery. Prog Biophys Mol Biol Elsevier Ltd. 2015;119(1):10\u20139. https:\/\/doi.org\/10.1016\/j.pbiomolbio.2015.05.002 .","journal-title":"Prog Biophys Mol Biol Elsevier Ltd"},{"issue":"6","key":"8301_CR12","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1038\/nchembio.2363","volume":"13","author":"T Uehara","year":"2017","unstructured":"Uehara T, Minoshima Y, Sagane K, Sugi NH, Mitsuhashi KO, Yamamoto N, et al. Selective degradation of splicing factor CAPER\u03b1 by anticancer sulfonamides. Nat Chem Biol. 2017;13(6):675\u201380. https:\/\/doi.org\/10.1038\/nchembio.2363 .","journal-title":"Nat Chem Biol"},{"issue":"1","key":"8301_CR13","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/nrm1547","volume":"6","author":"MD Petroski","year":"2005","unstructured":"Petroski MD, Deshaies RJ. Function and regulation of cullin\u2013RING ubiquitin ligases. Nat Rev Mol Cell Biol. 2005;6(1):9\u201320. https:\/\/doi.org\/10.1038\/nrm1547 .","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"2","key":"8301_CR14","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1074\/jbc.M110417200","volume":"277","author":"D-J Jung","year":"2002","unstructured":"Jung D-J, Na S-Y, Na DS, Lee JW. Molecular cloning and characterization of CAPER, a novel coactivator of activating Protein-1 and estrogen receptors. J Biol Chem. 2002;277(2):1229\u201334. https:\/\/doi.org\/10.1074\/jbc.M110417200 .","journal-title":"J Biol Chem"},{"issue":"1","key":"8301_CR15","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/S0021-9258(17)42373-8","volume":"269","author":"MM Zutter","year":"1994","unstructured":"Zutter MM, Santoro SA, Painter AS, Tsung YL, Gafford A. The human alpha 2 integrin gene promoter. Identification of positive and negative regulatory elements important for cell-type and developmentally restricted gene expression. J Biol Chem. 1994;269(1):463\u20139. https:\/\/doi.org\/10.1016\/S0021-9258(17)42373-8 .","journal-title":"J Biol Chem"},{"issue":"8","key":"8301_CR16","doi-asserted-by":"publisher","first-page":"3006","DOI":"10.1182\/blood.V86.8.3006.3006","volume":"86","author":"MM Zutter","year":"1995","unstructured":"Zutter MM, Painter AA, Staatz WD, Tsung YL. Regulation of alpha 2 integrin gene expression in cells with megakaryocytic features: a common theme of three necessary elements. Blood. 1995;86(8):3006\u201314. https:\/\/doi.org\/10.1182\/blood.V86.8.3006.3006 .","journal-title":"Blood."},{"key":"8301_CR17","doi-asserted-by":"publisher","first-page":"eaal3755","DOI":"10.1126\/science.aal3755","volume":"356","author":"T Han","year":"2017","unstructured":"Han T, Goralski M, Gaskill N, Capota E, Kim J, Ting TC, et al. Anticancer sulfonamides target splicing by inducing RBM39 degradation via recruitment to DCAF15. Science (80- ). 2017;356:eaal3755.","journal-title":"Science (80- )"},{"issue":"40","key":"8301_CR18","doi-asserted-by":"publisher","first-page":"42590","DOI":"10.18632\/oncotarget.6052","volume":"6","author":"Y Sang","year":"2015","unstructured":"Sang Y, Yan F, Ren X. The role and mechanism of CRL4 E3 ubiquitin ligase in cancer and its potential therapy implications. Oncotarget. 2015;6(40):42590\u2013602. https:\/\/doi.org\/10.18632\/oncotarget.6052 .","journal-title":"Oncotarget."},{"issue":"D1","key":"8301_CR19","doi-asserted-by":"publisher","first-page":"D733","DOI":"10.1093\/nar\/gkv1189","volume":"44","author":"NA O\u2019Leary","year":"2016","unstructured":"O\u2019Leary NA, Wright MW, Brister JR, Ciufo S, Haddad D, McVeigh R, et al. Reference sequence (RefSeq) database at NCBI: current status, taxonomic expansion, and functional annotation. Nucleic Acids Res. 2016;44(D1):D733\u201345. https:\/\/doi.org\/10.1093\/nar\/gkv1189 .","journal-title":"Nucleic Acids Res"},{"key":"8301_CR20","first-page":"129","volume":"1072","author":"P Angel","year":"1991","unstructured":"Angel P, Karin M. The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation. BBA - Rev Cancer. 1991;1072:129\u201357.","journal-title":"BBA - Rev Cancer"},{"key":"8301_CR21","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1016\/j.bbaexp.2007.06.004","volume":"1769","author":"Y Cheli","year":"2007","unstructured":"Cheli Y, Kanaji S, Jacquelin B, Chang M, Nugent DJ, Kunicki TJ. Transcriptional and epigenetic regulation of the integrin collagen receptor locus ITGA1-PELO-ITGA2. Biochim Biophys Acta - Gene Struct Expr. 2007;1769:546\u201358.","journal-title":"Biochim Biophys Acta - Gene Struct Expr"},{"key":"8301_CR22","doi-asserted-by":"publisher","first-page":"108708","DOI":"10.1016\/j.biopha.2019.108708","volume":"114","author":"X Wu","year":"2019","unstructured":"Wu X, Cai J, Zuo Z, Li J. Collagen facilitates the colorectal cancer stemness and metastasis through an integrin\/PI3K\/AKT\/snail signaling pathway. Biomed Pharmacother. 2019;114:108708. https:\/\/doi.org\/10.1016\/j.biopha.2019.108708 .","journal-title":"Biomed Pharmacother"},{"issue":"8","key":"8301_CR23","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1111\/cas.12450","volume":"105","author":"K Ito","year":"2014","unstructured":"Ito K, Semba T, Uenaka T, Wakabayashi T, Asada M, Funahashi Y. Enhanced anti-angiogenic effect of E7820 in combination with erlotinib in epidermal growth factor receptor-tyrosine kinase inhibitor-resistant non-small-cell lung cancer xenograft models. Cancer Sci. 2014;105(8):1023\u201331. https:\/\/doi.org\/10.1111\/cas.12450 .","journal-title":"Cancer Sci"},{"key":"8301_CR24","doi-asserted-by":"publisher","first-page":"43612","DOI":"10.1038\/srep43612","volume":"7","author":"CH Chung","year":"2017","unstructured":"Chung CH, Chang CH, Hsu CC, Lin KT, Peng HC, Huang TF. Aggretin Venom Polypeptide as a Novel Anti-angiogenesis Agent by Targeting Integrin alpha2beta1. Sci Rep. 2017;7:43612 Nature Publishing Group.","journal-title":"Sci Rep"},{"issue":"1","key":"8301_CR25","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.bone.2013.05.003","volume":"56","author":"R Stange","year":"2013","unstructured":"Stange R, Kronenberg D, Timmen M, Everding J, Hidding H, Eckes B, et al. Age-related bone deterioration is diminished by disrupted collagen sensing in integrin \u03b12\u03b21 deficient mice. Bone. 2013;56(1):48\u201354. https:\/\/doi.org\/10.1016\/j.bone.2013.05.003 .","journal-title":"Bone."},{"issue":"6","key":"8301_CR26","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1359\/jbmr.1999.14.6.893","volume":"14","author":"D Wang","year":"1999","unstructured":"Wang D, Christensen K, Chawla K, Xiao G, Krebsbach PH, Franceschi RT. Isolation and characterization of MC3T3-E1 Preosteoblast subclones with distinct in vitro and in vivo differentiation\/mineralization potential. J Bone Miner Res. 1999;14(6):893\u2013903. https:\/\/doi.org\/10.1359\/jbmr.1999.14.6.893 .","journal-title":"J Bone Miner Res"},{"issue":"18","key":"8301_CR27","first-page":"4961","volume":"47","author":"SB Rodan","year":"1987","unstructured":"Rodan SB, Imai Y, Thiede MA, Wesolowski G, Thompson D, Bar-Shavit Z, et al. Characterization of a human osteosarcoma cell line (Saos-2) with osteoblastic properties. Cancer Res. 1987;47(18):4961\u20136.","journal-title":"Cancer Res"},{"issue":"6","key":"8301_CR28","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1016\/0092-8674(89)90343-7","volume":"57","author":"RL Williams","year":"1989","unstructured":"Williams RL, Risau W, Zerwes H-G, Drexler H, Aguzzi A, Wagner EF. Endothelioma cells expressing the polyoma middle T oncogene induce hemangiomas by host cell recruitment. Cell. 1989;57(6):1053\u201363. https:\/\/doi.org\/10.1016\/0092-8674(89)90343-7 .","journal-title":"Cell."},{"key":"8301_CR29","first-page":"581","volume":"19","author":"N Filipovic","year":"2016","unstructured":"Filipovic N, Ghimire K, Saveljic I, Milosevic Z, Ruegg C. Computational modeling of shear forces and experimental validation of endothelial cell responses in an orbital well shaker system. Comput methods Biomech biomed Engin. Taylor Francis. 2016;19:581\u201390.","journal-title":"Taylor Francis"},{"issue":"4","key":"8301_CR30","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1080\/10915810701464641","volume":"26","author":"G Goel","year":"2007","unstructured":"Goel G, Makkar HPS, Francis G, Becker K. Phorbol esters: structure, biological activity, and toxicity in animals. Int J Toxicol. 2007;26(4):279\u201388. https:\/\/doi.org\/10.1080\/10915810701464641 .","journal-title":"Int J Toxicol"},{"issue":"1-2","key":"8301_CR31","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","volume":"65","author":"T Mosmann","year":"1983","unstructured":"Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods. 1983;65(1-2):55\u201363. https:\/\/doi.org\/10.1016\/0022-1759(83)90303-4 .","journal-title":"J Immunol Methods"},{"issue":"4","key":"8301_CR32","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2-\u0394\u0394CT method. Methods. 2001;25(4):402\u20138. https:\/\/doi.org\/10.1006\/meth.2001.1262 .","journal-title":"Methods."},{"key":"8301_CR33","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1126\/science.1244851","volume":"343","author":"J Kronke","year":"2014","unstructured":"Kronke J, Udeshi ND, Narla A, Grauman P, Hurst SN, McConkey M, et al. Lenalidomide Causes Selective Degradation of IKZF1 and IKZF3 in Multiple Myeloma Cells. Science (80- ). 2014;343:301\u20135.","journal-title":"Science (80- )"},{"issue":"1","key":"8301_CR34","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S0079-6336(02)80008-0","volume":"37","author":"DE Gullberg","year":"2002","unstructured":"Gullberg DE, Lundgren-\u00c5kerlund E. Collagen-binding I domain integrins \u2014 what do they do? Prog Histochem Cytochem. 2002;37(1):3\u201354. https:\/\/doi.org\/10.1016\/S0079-6336(02)80008-0 .","journal-title":"Prog Histochem Cytochem"},{"key":"8301_CR35","doi-asserted-by":"publisher","first-page":"4","DOI":"10.3390\/ijms21082835","volume":"21","author":"D Kronenberg","year":"2020","unstructured":"Kronenberg D, Michel PA, Hochstrat E, Wei M, Brinckmann J, M\u00fcller M, et al. Increased collagen turnover impairs tendon microstructure and stability in integrin \u03b12\u03b21-deficient mice. Int J Mol Sci. 2020;21:4\u20136.","journal-title":"Int J Mol Sci"},{"issue":"42","key":"8301_CR36","doi-asserted-by":"publisher","first-page":"26643","DOI":"10.1074\/jbc.272.42.26643","volume":"272","author":"H Obata","year":"1997","unstructured":"Obata H, Hayashi K, Nishida W, Momiyama T, Uchida A, Ochi T, et al. Smooth muscle cell phenotype-dependent transcriptional regulation of the alpha1 integrin gene. J Biol Chem. 1997;272(42):26643\u201351. https:\/\/doi.org\/10.1074\/jbc.272.42.26643 .","journal-title":"J Biol Chem"},{"issue":"2","key":"8301_CR37","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.preteyeres.2006.10.004","volume":"26","author":"F Vigneault","year":"2007","unstructured":"Vigneault F, Zaniolo K, Gaudreault M, Gingras M-E, Gu\u00e9rin SL. Control of integrin genes expression in the eye. Prog Retin Eye Res. 2007;26(2):99\u2013161. https:\/\/doi.org\/10.1016\/j.preteyeres.2006.10.004 .","journal-title":"Prog Retin Eye Res"},{"issue":"2","key":"8301_CR38","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.matbio.2005.10.002","volume":"25","author":"N Lu","year":"2006","unstructured":"Lu N, Heuchel R, Barczyk M, Zhang W-M, Gullberg D. Tandem Sp1\/Sp3 sites together with an Ets-1 site cooperate to mediate alpha11 integrin chain expression in mesenchymal cells. Matrix Biol. 2006;25(2):118\u201329. https:\/\/doi.org\/10.1016\/j.matbio.2005.10.002 .","journal-title":"Matrix Biol"},{"issue":"3","key":"8301_CR39","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.matbio.2009.11.003","volume":"29","author":"N Lu","year":"2010","unstructured":"Lu N, Carracedo S, Ranta J, Heuchel R, Soininen R, Gullberg D. The human alpha11 integrin promoter drives fibroblast-restricted expression in vivo and is regulated by TGF-beta1 in a Smad- and Sp1-dependent manner. Matrix Biol. 2010;29(3):166\u201376. https:\/\/doi.org\/10.1016\/j.matbio.2009.11.003  International Society of Matrix Biology.","journal-title":"Matrix Biol"},{"issue":"3","key":"8301_CR40","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1083\/jcb.140.3.709","volume":"140","author":"J Xu","year":"1998","unstructured":"Xu J, Zutter MM, Santoro SA, Clark RA. A three-dimensional collagen lattice activates NF-kappaB in human fibroblasts: role in integrin alpha2 gene expression and tissue remodeling. J Cell Biol. 1998;140(3):709\u201319. https:\/\/doi.org\/10.1083\/jcb.140.3.709 .","journal-title":"J Cell Biol"},{"key":"8301_CR41","doi-asserted-by":"publisher","first-page":"e938","DOI":"10.1038\/cddis.2013.461","volume":"4","author":"BE Engel","year":"2013","unstructured":"Engel BE, Welsh E, Emmons MF, Santiago-Cardona PG, Cress WD. Expression of integrin alpha 10 is transcriptionally activated by pRb in mouse osteoblasts and is downregulated in multiple solid tumors. Cell Death Dis. 2013;4:e938 Nature Publishing Group.","journal-title":"Cell Death Dis"},{"issue":"11","key":"8301_CR42","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1038\/nrc2505","volume":"8","author":"SJ Harper","year":"2008","unstructured":"Harper SJ, Bates DO. VEGF-A splicing: the key to anti-angiogenic therapeutics? Nat Rev Cancer. 2008;8(11):880\u20137. https:\/\/doi.org\/10.1038\/nrc2505 .","journal-title":"Nat Rev Cancer"},{"key":"8301_CR43","doi-asserted-by":"publisher","first-page":"2120","DOI":"10.3389\/fimmu.2019.02120","volume":"10","author":"H L\u00e4ubli","year":"2019","unstructured":"L\u00e4ubli H, Borsig L. Altered cell adhesion and glycosylation promote Cancer immune suppression and metastasis. Front Immunol. 2019;10:2120. https:\/\/doi.org\/10.3389\/fimmu.2019.02120 .","journal-title":"Front Immunol"},{"issue":"1","key":"8301_CR44","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/nrc2748","volume":"10","author":"JS Desgrosellier","year":"2010","unstructured":"Desgrosellier JS, Cheresh DA. Integrins in cancer: biological implications and therapeutic opportunities. Nat Rev Cancer. 2010;10(1):9\u201322. https:\/\/doi.org\/10.1038\/nrc2748 .","journal-title":"Nat Rev Cancer"},{"issue":"23","key":"8301_CR45","first-page":"8312","volume":"63","author":"C Yang","year":"2003","unstructured":"Yang C, Zeisberg M, Lively JC, Nyberg P, Afdhal N, Kalluri R. Integrin alpha1beta1 and alpha2beta1 are the key regulators of hepatocarcinoma cell invasion across the fibrotic matrix microenvironment. Cancer Res. 2003;63(23):8312\u20137.","journal-title":"Cancer Res"},{"key":"8301_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13046-018-1018-6","volume":"38","author":"D Ren","year":"2019","unstructured":"Ren D, Zhao J, Sun Y, Li D, Meng Z, Wang B, et al. Overexpressed ITGA2 promotes malignant tumor aggression by up-regulating PD-L1 expression through the activation of the STAT3 signaling pathway. J Exp Clin Cancer Res. 2019;38:1\u201318.","journal-title":"J Exp Clin Cancer Res"},{"key":"8301_CR47","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.jprot.2017.06.021","volume":"168","author":"Q Yang","year":"2017","unstructured":"Yang Q, Bavi P, Wang JY, Roehrl MH. Immuno-proteomic discovery of tumor tissue autoantigens identifies olfactomedin 4, CD11b, and integrin alpha-2 as markers of colorectal cancer with liver metastases. J Proteomics. 2017;168:53\u201365 Elsevier B.V.","journal-title":"J Proteomics"},{"issue":"8","key":"8301_CR48","doi-asserted-by":"publisher","first-page":"2106","DOI":"10.1002\/cncr.26488","volume":"118","author":"G Huang","year":"2012","unstructured":"Huang G, Zhou Z, Wang H, Kleinerman ES. CAPER-\u03b1 alternative splicing regulates the expression of vascular endothelial growth factor165 in Ewing sarcoma cells. Cancer. 2012;118(8):2106\u201316. https:\/\/doi.org\/10.1002\/cncr.26488 .","journal-title":"Cancer."}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-021-08301-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-021-08301-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-021-08301-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,18]],"date-time":"2021-05-18T21:03:23Z","timestamp":1621371803000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-021-08301-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,18]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["8301"],"URL":"https:\/\/doi.org\/10.1186\/s12885-021-08301-w","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,18]]},"assertion":[{"value":"2 February 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 May 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Human umbilical vein endothelial cells (HUVECs) from healthy donors were provided in accordance with the approval given by the ethics board of the University of M\u00fcnster (Ethik-Kommission der \u00c4rztekammer Westfalen-Lippe und der Westf\u00e4lischen Wilhelms-Universit\u00e4t, reference Number. 2009\u2013537-f-S). All experiments were perfomed in accordance with local guidlines and regulations. Informed consent was obtained from all patients or, if patients are under 16, from a parent and\/or legal guardian. There are no ways to connect the results of this study with any personally identifiable data including biomedical, clinical, and biometric data.All murine and further human cell lines are provided by commercial available suppliers. No animal experiments were performed in this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"571"}}